Last updated 2026-07-26
- Raised $6.4M Seed round, May 2020
- Raised $1M Series A, Dec 2022
Total raised
$7.4M
Last: Undisclosed Round 2023-01
Stage
Series A
Founded
2020
Headcount
10
HQ
Yehud-Monosson, Israel
Sector
Health Tech & Life Sciences
About
Curespec is an Israeli MedTech company that has developed Nephrospec™, a non-invasive device utilizing electro-Hydraulic Acoustic Therapy (eHAT) to treat chronic kidney disease (CKD) and hypertension. The technology aims to promote new blood vessel formation and restore damaged tissue function in the kidneys, thereby improving kidney function and lowering blood pressure, potentially delaying or avoiding the need for dialysis. The company operates on a high-margin model combining device sales and recurring consumables, alongside pay-per-treatment options.
Funding history · 2 rounds · $7.4M total
2022-12
A Round
$1.0M
2020-05
Seed
$6.4M
Headcount over time
From 2 (2022-02) to 9 (2025-04) · +7 (+350%) · 8 points · source: Finder history + radar grounding
Q&A
- What is Curespec's primary product?
- Curespec developed Nephrospec™, a noninvasive device that utilizes electro-Hydraulic Acoustic Therapy (eHAT) to improve kidney function and reduce systolic blood pressure, aiming to treat chronic kidney disease (CKD) and hypertension.
- What is Curespec's total funding to date?
- Curespec has raised a total of $13,000,000 USD.
- What is the employee count for Curespec?
- Curespec has 10 employees, falling within the 1-10 employee bucket.
- What regulatory approvals has Curespec obtained for its Nephrospec device?
- Curespec has obtained CE approval in Europe and AMAR approval in Israel for its Nephrospec device.
- What is the business model of Curespec?
- Curespec operates on a high-margin model that combines device sales and recurring consumables, alongside pay-per-treatment options.
- Who are the co-founders of Curespec?
- The co-founders of Curespec are Avner Spector and Alex Slutzker.
Team · 2
Avner Spector
Founder · Co-founder & Chairman
Alex Slutzker
Founder · Co-Founder
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Target customers
Healthcare & Life SciencesHealthcareProvidersPatients
Business model
B2CB2B
Highlights
1 PatentsVerified
Tags
chronic-diseasetissue-regenerationcardiologypain-reliefhospitalsnephrologyblood-pressurenon-invasivedialysisclinicstreatmentsmedical-devicesmedical-technologies
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | curespec.info |
|---|---|
| linkedin.com/company/80680321 | |
| facebook.com/Curespec | |
| instagram.com/curespec |
Identifiers & details
| Legal name | Curespec Ltd. |
|---|---|
| Founded | 2020 |
| Employees (exact) | 10 |
Radar intelligence
Patents
| EPO | 1 |
|---|
Publications (Crossref)
| Works | 1 |
|---|
Web history (Wayback)
| Domain | curespec.info |
|---|
Certificate / subdomain footprint
| Subdomains | 2 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 516299351 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2020-12-21 |
| Purpose | לעסוק בסוגי עיסוק שפורטו בתקנון |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2025 |
| Active charges / liens | 0 |
| Registry events | 3 — other (1), people (2) |
| Registered address | התעשייה 40 יהוד-מונוסון |
Recent registry events
| Date | Event |
|---|---|
| 2025-07-31 | עדכון כתובת ו/או מען דיגיטלי |
| 2026-02-17 | עדכון דירקטורים-הסרת דירקטור |
| 2026-02-11 | עדכון דירקטורים-הוספת דירקטור |